ChromaDex’s net loss was $1.84m, compared to $303,529 for the same period in the prior year.
The company’s operating loss was $1.83m for the second quarter ended July 2011, as compared to $293,200 for the same period in 2010.
For the second quarter ended July 2011, the company has earned gross profit of $580,918, as compared to $775,689 for the same period prior year.
ChromaDex is a provider of proprietary, science-based solutions and ingredients to the dietary supplement, pharmaceutical, food & beverage and cosmetic industries.